Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 37,800 shares at $61.87 ($2.3M) on 2020-12-01, disclosed to the SEC on 2020-12-03.
Open-market sale of $2.3M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.23 | 6,480 | $390K | 17.0% |
| 2 | $60.23 | 6,480 | $390K | 17.0% |
| 3 | $61.16 | 11,309 | $692K | 30.1% |
| 4 | $61.16 | 11,309 | $692K | 30.1% |
| 5 | $61.87 | 1,011 | $63K | 2.7% |
| 6 | $61.87 | 1,011 |
| $63K |
| 2.7% |
| 7 | $62.94 | 200 | $13K | 0.5% |
| Total | $60.89 avg | 37,800 | $2.3M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |